AREL1 anticorps (Middle Region)
-
- Antigène Tous les produits AREL1
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AREL1 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- KIAA0317 antibody was raised against the middle region of KIAA0317
- Purification
- Affinity purified
- Immunogène
- KIAA0317 antibody was raised using the middle region of KIAA0317 corresponding to a region with amino acids VRARFTRSFLAQIIGLRMHYKYFETDDPEFYKSKVCFILNNDMSEMELVF
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
KIAA0317 Blocking Peptide, catalog no. 33R-9768, is also available for use as a blocking control in assays to test for specificity of this KIAA0317 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KIAA0317 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
- Autre désignation
- KIAA0317 (AREL1 Produits)
- Synonymes
- anticorps KIAA0317, anticorps apoptosis resistant E3 ubiquitin protein ligase 1, anticorps AREL1
- Sujet
- KIAA0317 contains 1 filamin repeat and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. The exact function of KIAA0317 remains unknown.
- Poids moléculaire
- 94 kDa (MW of target protein)
-